Risk Factors of Pneumocystis Jiroveci Pneumonia (PJP) in Patients with RA and Sulfasalazine As a Possible Protective Agent

被引：0
|
作者：
Motojima, Shinji [1 ]
Nakashita, Tamao [1 ]
Jibatake, Akira [1 ]
Yoshida, Akira [1 ]
Yamamoto, Yoshiki [1 ]
机构：
[1] Kameda Med Ctr, Dept Rheumatol & Allergy, Kamogawa City, Japan
来源：
ARTHRITIS & RHEUMATOLOGY | 2016年 / 68卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2643
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Preventive effect of sulfamethoxasole-trimethoprim on Pneumocystis jiroveci pneumonia in patients with interstitial pneumonia
    Enomoto, Tatsuji
    Azuma, Arata
    Matsumoto, Aki
    Nei, Takahito
    Fujita, Kazue
    Hattori, Kumiko
    Saito, Yoshinobu
    Abe, Shinji
    Usuki, Jiro
    Kudoh, Shoji
    INTERNAL MEDICINE, 2008, 47 (01) : 15 - 20
  • [42] Pneumocystis jiroveci pneumonia in immunocompromised patients without AIDS - a case series
    Blum, T.
    Roth, A.
    Mauch, H.
    Erbes, R.
    Lode, H.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2006, 131 (27) : 1515 - 1520
  • [43] Resistant Pneumocystis Jiroveci Pneumonia in Patients With ANCA-Associated Vasculitis
    Xiong, J.
    Prasad, S.
    Embry, E.
    Singh, K.
    Singh, M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [44] Genotypic resistance to sulfamide drugs among patients with Pneumocystis jiroveci pneumonia
    Calderón, E
    de la Horra, C
    Montes-Cano, MA
    Respaldiza, N
    Varela, JMJYJM
    MEDICINA CLINICA, 2004, 122 (16): : 617 - 619
  • [45] Pneumocystis jiroveci pneumonia in immunosuppressed connective tissue disease patients.
    O'Brien, Marie S.
    Ingraham, Kristin M.
    Cupps, Thomas R.
    Derk, Chris T.
    ARTHRITIS AND RHEUMATISM, 2006, 54 (12): : 4061 - 4061
  • [46] Safety of Dapsone for Pneumocystis Jiroveci Pneumonia Prophylaxis in Patients With Multiple Myeloma
    Kim, Mingee
    Arabi, Jessica
    McCoy, Cole
    D'Souza, Anita
    Chhabra, Saurabh
    Abid, Muhammad Bilal
    Thapa, Bicky
    Dhakal, Binod
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 (11): : 804 - 807
  • [47] Clindamycin-primaquine for pneumocystis jiroveci pneumonia in renal transplant patients
    Nickel, P.
    Schuermann, M.
    Albrecht, H.
    Schindler, R.
    Budde, K.
    Westhoff, T.
    Millward, J.
    Suttorp, N.
    Reinke, P.
    Schuermann, D.
    INFECTION, 2014, 42 (06) : 981 - 989
  • [48] Incidence of Pneumocystis Jiroveci Pneumonia in Patients Following Intestinal Transplantation.
    Yeap, Sze
    Gkrania-Klotsas, Effrossyni
    Sharkey, Lisa M.
    Middleton, Stephen J.
    Woodward, Jeremy M.
    Butler, Andrew J.
    Russell, Neil K.
    Gibbs, Paul
    Bond, Diane
    Duncan, Samantha
    Massey, Dunecan C. O.
    TRANSPLANTATION, 2017, 101 (06) : S49 - S49
  • [49] Comparison of Pneumocystis jiroveci pneumonia characteristics in patients with and without HIV infection
    Luisa Aznar, Maria
    Perez-Fernandez, Naiara
    Ruiz-Camps, Isabel
    Teresa Martin-Gomez, M.
    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2014, 32 (08): : 545 - 547
  • [50] HTLV-1-Associated Adult T Cell Leukemia Lymphoma Presenting as Granulomatous Pneumocystis Jiroveci Pneumonia (PJP) and Hypercalcemia
    Sabiha Shahnaz
    David Reich
    Diana Arévalo-Valencia
    Slavka Kucinska
    Joanna Tulczynska
    Jean Fleischman
    Journal of General Internal Medicine, 2007, 22 : 420 - 423
12345